Eiichi Sato Selected Research

Eiichi Sato Research Topics

Disease

54	Neoplasms (Cancer) 11/2022 - 01/2002
14	Proteinuria 01/2021 - 11/2009
13	Chronic Renal Insufficiency 01/2020 - 11/2009
9	Testicular Neoplasms (Testicular Cancer) 11/2018 - 12/2005
7	Esophageal Neoplasms (Esophageal Cancer) 11/2021 - 01/2006
7	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2010
6	Melanoma (Melanoma, Malignant) 11/2021 - 03/2005
6	Dyslipidemias (Dyslipidemia) 01/2021 - 12/2009
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 02/2005
6	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2013
6	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2017 - 01/2014
5	Stomach Neoplasms (Stomach Cancer) 01/2020 - 03/2004
5	Type 2 Diabetes Mellitus (MODY) 07/2017 - 11/2002
5	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2015 - 11/2002
4	Disease Progression 01/2020 - 06/2009
4	Ductal Carcinoma 12/2017 - 01/2002
3	Infections 02/2021 - 05/2002
3	Triple Negative Breast Neoplasms 07/2020 - 01/2019
3	Atherosclerosis 01/2020 - 02/2005
3	Adenocarcinoma of Lung 01/2020 - 01/2017
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2020 - 01/2016
3	Body Weight (Weight, Body) 07/2017 - 04/2015
3	Injection Site Reaction 05/2017 - 12/2011
3	Fever (Fevers) 05/2017 - 12/2011
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2016 - 02/2011
3	Inflammation (Inflammations) 01/2016 - 09/2006
3	Anemia 04/2013 - 09/2009
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2013 - 07/2009
3	Lymphoma (Lymphomas) 03/2012 - 11/2002
3	Septic Shock (Toxic Shock Syndrome) 12/2011 - 12/2009
3	Carcinoma (Carcinomatosis) 05/2010 - 06/2002
3	Rheumatoid Arthritis 10/2003 - 08/2002
2	Esophageal Squamous Cell Carcinoma 11/2022 - 04/2020
2	Lung Neoplasms (Lung Cancer) 11/2021 - 10/2014
2	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 01/2016
2	Anorexia 04/2020 - 01/2016
2	Hypertension (High Blood Pressure) 04/2020 - 01/2012
2	Hepatocellular Carcinoma (Hepatoma) 06/2019 - 12/2004
2	Oral Lichen Planus 01/2018 - 07/2003

Drug/Important Bio-Agent (IBA)

19	AntigensIBA 11/2022 - 12/2005
18	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2005
12	Retinaldehyde (Retinal)IBA 11/2012 - 09/2002
9	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2011
9	Monoclonal AntibodiesIBA 04/2020 - 11/2002
8	VaccinesIBA 11/2022 - 11/2008
8	Fatty Acid-Binding ProteinsIBA 11/2019 - 12/2009
6	Cancer VaccinesIBA 04/2020 - 04/2007
6	CreatinineIBA 06/2018 - 11/2009
6	8-Hydroxy-2'-DeoxyguanosineIBA 01/2012 - 12/2009
5	Indicators and Reagents (Reagents)IBA 11/2021 - 03/2005
5	LDL CholesterolIBA 01/2021 - 01/2010
5	Pharmaceutical PreparationsIBA 04/2020 - 03/2003
5	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2017
5	LipidsIBA 01/2020 - 11/2009
5	CholesterolIBA 06/2018 - 04/2007
5	Advanced Glycation End ProductsIBA 05/2012 - 11/2009
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2009 - 09/2002
4	pullulanIBA 11/2022 - 04/2007
4	Neoplasm Antigens (Tumor Antigens)IBA 11/2021 - 11/2008
4	Peptides (Polypeptides)IBA 04/2020 - 12/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2002
4	Interleukin-6 (Interleukin 6)IBA 10/2019 - 12/2009
4	PicibanilIBA 05/2017 - 11/2009
4	CytokinesIBA 01/2016 - 10/2008
4	Messenger RNA (mRNA)IBA 05/2013 - 01/2005
4	HMGB1 Protein (HMG1)IBA 01/2012 - 12/2009
4	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2010 - 11/2009
4	Biological ProductsIBA 10/2009 - 01/2002
3	oxidized low density lipoproteinIBA 01/2021 - 11/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2011
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 03/2012
3	EpitopesIBA 04/2020 - 04/2007
3	Ezetimibe (Zetia)FDA Link 06/2018 - 12/2009
3	Tolvaptan FDA Link 01/2017 - 01/2014
3	Transcription Factors (Transcription Factor)IBA 01/2016 - 12/2012
3	Receptor for Advanced Glycation End ProductsIBA 12/2011 - 11/2009
3	EndotoxinsIBA 12/2011 - 12/2009
3	Polymyxin B (Aerosporin)FDA LinkGeneric 12/2011 - 07/2009
3	LigandsIBA 12/2009 - 07/2003
3	Oxygen (Dioxygen)IBA 10/2008 - 09/2002
3	NG-Nitroarginine Methyl Ester (L-NAME)IBA 10/2008 - 09/2002
3	Chemokine CCL5IBA 01/2005 - 07/2003
3	ChemokinesIBA 01/2005 - 07/2003
2	Immunoglobulin A (IgA)IBA 11/2022 - 01/2016
2	Surface Antigens (Surface Antigen)IBA 01/2022 - 01/2016
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2012
2	Combined VaccinesIBA 11/2021 - 11/2009
2	poly ICLCIBA 11/2021 - 05/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2018 - 01/2010
2	Atorvastatin (Lipitor)FDA Link 06/2018 - 09/2010
2	Phenobarbital (Luminal)FDA Link 12/2017 - 05/2013
2	Hormones (Hormone)IBA 12/2017 - 05/2017
2	AST 120IBA 10/2016 - 02/2011

Therapy/Procedure

18	Therapeutics 11/2022 - 01/2006
9	Immunotherapy 01/2020 - 01/2006
7	Lasers (Laser) 05/2011 - 11/2002
4	Blood Component Removal (Apheresis) 01/2021 - 11/2014
4	Drug Therapy (Chemotherapy) 04/2020 - 09/2006
3	Neoadjuvant Therapy 01/2020 - 05/2013
3	Hemoperfusion 12/2011 - 07/2009